What are the responsibilities and job description for the Medical Director, Hematology/Oncology position at Jazz Pharmaceuticals?
About Us: Jazz Pharmaceuticals is a global biopharmaceutical company committed to developing life-changing medicines for patients with serious diseases. Our innovative approach and dedicated team drive our mission to improve lives through transformative treatments.
Jazz Pharmaceuticals' focus on hematology and oncology enables us to provide meaningful therapies for patients in need. As we continue to grow and expand our pipeline, we seek experienced professionals to join our team.
Your Role: The Director, Clinical Development, will lead the clinical development of new and existing programs within our Hematology/Oncology Therapeutic Area. Responsibilities include medical leadership, protocol development, data interpretation, and regulatory interactions. This role requires collaboration with cross-functional teams to ensure successful program execution.
Key Responsibilities:
Jazz Pharmaceuticals' focus on hematology and oncology enables us to provide meaningful therapies for patients in need. As we continue to grow and expand our pipeline, we seek experienced professionals to join our team.
Your Role: The Director, Clinical Development, will lead the clinical development of new and existing programs within our Hematology/Oncology Therapeutic Area. Responsibilities include medical leadership, protocol development, data interpretation, and regulatory interactions. This role requires collaboration with cross-functional teams to ensure successful program execution.
Key Responsibilities:
- Provide strategic medical input for clinical programs and protocols
- Collaborate with internal stakeholders to develop and execute clinical trials
- Serve as medical monitor on trials and make recommendations based on safety findings
- Review and approve safety and efficacy data in clinical study reports and regulatory documents
- Engage external experts to integrate current clinical practice and guidelines into global clinical development plans
